baber/WOPTO huggingface dataset:
Patent AT-E269183-T1 (AT)
Inventor: STUER WILLEM DENIS MARIA
IPC: F01N1/00
Filed: 1999-04-13
Granted: 2004-07-15
Abstract: A method for the production of the housing of a silencer comprises the following steps:   providing a piece (2) of wall material having two opposing longitudinal edges (5, 6), shaping the piece (2) of wall material such that longitudinal edge portions (3, 4) forming the opposing longitudinal edges (5, 6) come to lie on one another, welding said longitudinal edge portions (3, 4) to one another with the formation of a tubular body (1) having a continuous weld seam extending along the entire length of the longitudinal edge portions (3, 4).   The welding includes resistance welding by means of two electrodes arranged on opposite sides of the overlapping edge portions (3, 4). The method gives a robust, gas tight and substantially flat join and is economical. <IMAGE>
Patent AT-E258295-T1 (AT)
Inventor: ZIMMERMANN KURT
IPC: B64F1/305
Filed: 1999-05-19
Granted: 2004-02-15
Abstract: A winder body (2) is rotatable around a horizontal axis and is driven by an electric gear motor (15). When not in use, the h is wound around the winder in a flatly pressed state in superimposed layers. An axial rotary seal is arranged on the winder body feeding air to the hose. An electrically operated magnet coupling (16) transmits the gear motor (15) torque to the winder body and in the current le state is released, so that the winder body is freely rotatable. A single operating component is connectable to the magnet coupli and at the same time the gear motor is set in motion in a rotary direction, in which the hose is wound up.
Patent AT-E257767-T1 (AT)
Inventor: REJC OTA
IPC: B09B3/00
Filed: 1999-02-08
Granted: 2004-01-15
Abstract: The unit for processing industrial rubber and plastic waste consists of a gasproof chamber (1), in which upper rollers (2) and lower rollers (3) are located in rows. The processed waste (4) passes between them, between the input and the output of the chamber (1). The lower rollers (3) are fixed in their position and the upper rollers are movable and attached by means of springs (5), which press them on the waste (4). The rollers (2 and 3) counter-rotate and the upper rollers (2) have projections (8) on their surface. The input area (10) with the input lifting closure (12) is placed on one front outer wall of the chamber (1) and the output area (14) with the output lifting closure (16) is placed on the opposite front outer wall of the chamber (1). Each area (10 and 14) is provided with a gas pipe (13) is located on the outer bottom wall of the chamber (1) and is separated from the chamber (1) by the inner lifting closure (11). In the alternative type the unit consists of at least two joined unit-built chambers (1), the input area (10) with the input lifting closure (12) is located on one front outer wall of the unit. The output area (14) with the output lifting closure (16) is located on the opposite front outer wall of the unit.
Patent AT-E368531-T1 (AT)
Inventor: NARUSHIMA SHIGEKI
IPC: B30B15/06
Filed: 1999-01-27
Granted: 2007-08-15
Abstract: A plate thickness reduction system is provided with a pair of dies 2 provided opposite each other on the upper and lower sides of a slab 1, a swing device 10 that moves up and down the dies symmetrically of the slab via eccentric shafts or crank shafts, upper and lower bearings 21, 22 that support the rotation of the eccentric shafts or crank shafts, and a bearing moving device that moves up and down at least one of the bearings. The bearing moving device is comprised of screw jacks 27 that are fixed to a main frame 26 and drive up and down the shaft boxes 25, or a wedge plate 28 or a step plate 29 that are inserted between and held by the main frame 26 and the shaft boxes 25, thus the thickness of a slab after being highly reduced can be easily adjusted using the same dies.  <IMAGE>
Patent AT-E281844-T1 (AT)
Inventor: ROY KRISHNENDU
IPC: A61K47/36
Filed: 1999-01-15
Granted: 2004-11-15
Abstract: Nanoparticle coacervates of nucleic acids and polycations serve as effective vaccines when administered orally. They can induce immunity to a variety of disease causing agents and raise a protective response to allergens.
Patent AT-E242873-T1 (AT)
Inventor: KERN RALF
IPC: G01L5/06
Filed: 1999-02-03
Granted: 2003-06-15
Abstract: An apparatus and a method for speech recognition are provided, by which, whereby the speech is optionally input via a microphone ( 14 ) close to the speaker or a microphone ( 20 ) remote from the speaker. A correction unit ( 15 ) is connected into the transmission channel ( 12 ) with microphone ( 14 ) close to the speaker, the correction unit modifying the electrical speech signal in such a way that it contains room transmission characteristics.
Patent AT-E383704-T1 (AT)
Inventor: SAYEGH SOHEIL
IPC: H04L7/04
Filed: 1999-05-13
Granted: 2008-01-15
Abstract: A method and apparatus for determining initial carrier and symbol phase estimates in a burst mode digital communication system are described. In-phase and quadrature sample of a BPSK preamble are sampled to obtain correlation values. Next, sum and differences of the correlation values are obtained. Then the initial carrier phase estimate (THETAHAT) and the initial symbol phase estimate (TAUHAT) are obtained through application of an algorithm. The apparatus that implements the method consists of adders, inverters, arc tangent look-up tables and divide by 2 logic units.
Patent AT-E309322-T1 (AT)
Inventor: WILLMAN KENNETH WILLIAM
IPC: A47L13/17
Filed: 1999-05-18
Granted: 2005-11-15
Abstract: A detergent composition for use with a disposable cleaning pad preferably comprising an effective amount of a superabsorbent material, said pad preferably being part of a cleaning implement comprising a handle and said cleaning pad preferably being removable. The detergent composition contains a disappearing dye and, preferably, limited amount of detergent surfactant, preferably linear in structure and relatively hydrophilic, the level of hydrophobic materials preferably being kept below about 3 %, and the pH preferably being above about 9, to allow the superabsorbent material to be readily absorbed by superabsorbent material. The process of using the detergent composition with such a cleaning pad, and the provision of a kit containing both detergent composition and cleaning pad are disclosed.
Patent AT-E275445-T1 (AT)
Inventor: GOTTSCHALK CHRISTIANE
IPC: B08B3/08
Filed: 1999-06-04
Granted: 2004-09-15
Abstract: The invention relates to a method and system for cleaning semiconductor elements accommodated in a tank which uses ozonized, deionized (DI) ultrapure water. According to the invention, ozone is generated in an ozone generator ( 3 ) according to the principal of silent electric discharge while admitting highly pure oxygen. Said ozone is fed to a contactor ( 7 ) through which DI water flows. The ozone is then dissolved in the DI water. While optionally admitting additional chemicals, the ozonized DI water is conducted through the tank ( 12 ) holding the semiconductor elements in order to clean the same, and the used DI water is carried away ( 15 ). In order to stabilize the ozone concentration, CO<SUB>2 </SUB>is added to the ozone/oxygen mixture generated by the ozone generator ( 7 ).
Patent AT-E262425-T1 (AT)
Inventor: KEMP PRESTON BUTLER JR
IPC: B60C11/00
Filed: 1999-08-09
Granted: 2004-04-15
Abstract: An opaque article having a surface and substantially asymmetric striae extending along the surface. A portion of the striae reside in a first area and have an orientation. Another portion of the striae reside in a second area and have an orientation substantially opposite the striae in the first area. The first area striae and the second area striae create an optical contrast therebetween at a wide range of viewing angles and illumination angles. The opaque article can be a tire. The striae can reside at numerous locations on the tire, including, for example, the sidewall, tread ribs or blocks, and stone ejectors.
Patent AT-E255894-T1 (AT)
Inventor: ALLGEIER HANS
IPC: C07D213/06
Filed: 1999-09-30
Granted: 2003-12-15
Abstract: The invention provides the use of selective mGluR5 antagonists for the treatment of pain and anxiety, and the use of mGluR antagonists for the treatment of pain, whereby analgesic effect is achieved by interaction of said antagonists primarily or predominantly at peripheral mGluR receptors.
Patent AT-E410506-T1 (AT)
Inventor: VAN BREE JOHANNES
IPC: A61K9/08
Filed: 1999-12-06
Granted: 2008-10-15
Abstract: The invention provides methods of treating Pompe's disease using human acid alpha glucosidase. A preferred treatment regime comprises administering greater than 10mg/kg body weight per week to a patient.
Patent AT-E250453-T1 (AT)
Inventor: RALL RICHARD R
IPC: B01J38/30
Filed: 1999-12-14
Granted: 2003-10-15
Abstract: A gas-solid fluidized bed is formed within a contacting element having pairs of planar portions arranged in intersecting planes, each planar portion being formed by one or more webs and one or more open slots adjacent each web, the webs and slots being arranged such that a web in one of the planar portions intersects a slot in the paired planar portion. The fluidized bed can be catalyst particles fluidized by a gas stream, such as in a catalyst stripper and/or regenerator in an FCC system.
Patent AT-E354877-T1 (AT)
Inventor: CAPRARA ANDREA
IPC: G02F1/37
Filed: 1999-10-18
Granted: 2007-03-15
Abstract: External-cavity optically-pumped semiconductor lasers (OPS-lasers) including an OPS-structure having a mirror-structure surmounted by a surface-emitting, semiconductor multiplayer (periodic) gain-structure are disclosed. The gain-structure is pumped by light from diode-lasers. The OPS-lasers can provide fundamental laser output-power of about two Watts (2.0 W) or greater. Intracavity frequency-converted arrangements of the OPS-lasers can provide harmonic laser output-power of about one-hundred milliwatts (100 mW) or greater, even at wavelengths in the ultraviolet region of the electromagnetic spectrum. These high output powers can be provided even in single axial-mode operation. Particular features of the OPS-lasers include a heat sink-assembly for cooling the OPS-structure, a folded resonator concept for providing optimum beam size at optically-nonlinear crystals used for frequency conversion, preferred selection of optically-nonlinear materials for frequency-conversion, and compound resonator designs for amplifying second harmonic-radiation for subsequent conversion to third or fourth harmonic radiation.
Patent DE-01900612-T1 (DE)
Inventor: DANIEL RONEN
IPC: H04M3/42
Filed: 2001-01-14
Abstract: For use in a cellular telecommunications network including a plurality of individually addressable Base Transceiver Stations (BTSs) providing bidirectional signal coverage over a predefined geographical area, and each capable of transmitting at least some interactive display messages, where each interactive display message enables a subscriber to automatically activate a response mechanism integrally provided in a display message and actuable by a dedicated response means associated therewith, a method for operating a personal cellular telecommunications device having at least one dynamic storage buffer, and a subscriber interface including a split screen display screen including a first portion and a second portion.
Patent DE-06720834-T1 (DE)
Title: Verfahren zur herstellung von blutplättchenanaloga
Inventor: CARVER FRANKLIN J
IPC: G01N33/48
Filed: 2006-02-15
Abstract: Verfahren
zur Herstellung von humanen Blutplättchenanaloga zur Verwendung
als Referenzkontrollen in automatischen Blutzellanalysatoren, wobei das
Verfahren Folgendes umfasst:  (a) Behandeln roter Blutkörperchen
eines nichthumanen Vertebraten, deren Größe durch Extraktion von Zellflüssigkeit
reduziert wurde und die mit einem Fixierungsmittel fixiert wurden,
durch Erhitzen der Zellen in Abwesenheit eines Fixierungsmittels
bis zu einem Grad, der ausreicht, um eine denaturierende Wirkung
zu erzielen; und  (b) Umsetzen der Zellen mit einem Fixierungsmittel
nach dem Erhitzen.
Patent DE-22159849-T1 (DE)
Title: Verfahren, vorrichtungen und trägerstrukturen zum zusammenbau von optischen fasern in katheterspitzen
Inventor: GÓMEZ SARA MAS
IPC: A61B18/14
Filed: 2022-03-03
Abstract: Katheter, aufweisend:einen proximalen Abschnitt;einen distalen Abschnitt;einen Schaft, der zwischen dem proximalen Abschnitt und dem distalen Abschnitt angeschlossen ist; undoptische Fasern, die sich durch den Schaft bis zum distalen Abschnitt des Katheters erstrecken, wobei der distale Abschnitt aufweist:eine Halterungsstruktur, aufweisend:ein proximales Ende mit Ausrichtaufnahmen, wobei jede der optischen Fasern in eine entsprechende der Ausrichtaufnahmen eingesetzt ist und die Ausrichtaufnahmen geformt sind, um die optischen Fasern in der Halterungsstruktur gestreckt zu halten; undein distales Ende mit Öffnungen, die in verschiedene Richtungen weisen;reflektierende Elemente;Linsen, wobei jede der optischen Fasern mit entsprechenden der Linsen, reflektierenden Elemente und Öffnungen optisch so ausgerichtet ist, dass die optischen Fasern in der Halterungsstruktur gestreckt sind und über die Öffnungen einen optischen Zugang zum Außenbereich des Katheters haben; undeine Kappe, die über einem Teilbereich des distalen Endes der Halterungsstruktur angeordnet ist, wobei die Kappe optische Durchlässe aufweist, die mit den Öffnungen ausgerichtet sind.
Patent DE-316067-T1 (DE)
IPC: A23K1/00
Filed: 1988-10-07
Abstract: This invention relates to a method of producing animal feed products.   A method of producing animal feed products using rapeseed is described wherein rapeseed is mixed together with the species Vicia Faba (field beans) in predetermined proportions and the mix is extruded at a predetermined temperature to substantially inactivate components in the rapeseed and said species which otherwise directly or indirectly cause components in the extruded product which are detrimental when contained in an animal feed product.
Patent ES-2265306-T1 (ES)
Inventor: SOUCHON DAVID
IPC: E04H12/08
Filed: 2005-07-07
Abstract: The mast comprises a pole body (4) that is connected to a strap (10) at one end. A pole body (6) has a polygonal base and is connected to a base plate (8) at another end and to the strap at the former end. The pole body (6) has a transversal encumbrance strictly lesser than a transversal space defined by the pole body (4) such that a gap (11) separates the body (4) from the body (6) along their circumference. An independent claim is also included for a method for manufacturing a mast.
Patent ES-2038112-T1 (ES)
Title: Mecanismo de activacion para tensor de cinturon.
IPC: B60R22/46
Filed: 1991-08-16
Abstract: UN MECANISMO DE DISPARO PARA RIGIDIZADOR DE CINTURON POSEE UNA MASA SENSORA QUE RESPONDE TANTO CON UN CHOQUE DELANTERO COMO CON UN CHOQUE TRASERO DEL VEHICULO. LA MASA SENSORA SE PUEDE MONTAR GIRATORIA Y PUEDE ESTAR FORMADA POR PIEZAS DE FUNCION DEL ACCIONAMIENTO DEL RIGIDIZADOR. EN UN RIGIDIZADOR DE CINTURON UNIDO CON UN ENROLLADOR DEL CINTURON (10) EN UN SUBCONJUNTO, EL CUAL TIENE UN ACCIONAMIENTO POR PISTON/CILINDRO PIROTECNICO, SE COMPONE LA MASA SENSORA DE UN BLOQUE SOPORTE (40) APOYADO EN UNA BASE GIRATORIA (12) CON EL CILINDRO GUIA (42) SUJETO A ELLA Y EL PISTON CORRESPONDIENTE. UNA PALANCA DE IMPACTO (50) MONTADA GIRATORIA EN LA BASE (12) SE LIBERA PARA ACTIVAR UN ENCENDEDOR DE IMPACTO EN UN CARTUCHO GENERADOR DE GAS (44), CUANDO EL BLOQUE PORTADOR (40) SE GIRA EN UNA O EN OTRA DIRECCION SENSIBLE DEL VEHICULO.
Patent ES-2082732-T1 (ES)
Inventor: ZAPOL WARREN M
IPC: A61K31/21
Filed: 1991-12-05
Abstract: A method for treating or preventing bronchoconstriction or reversible pulmonary vasoconstriction in a mammal, which method includes causing the mammal to inhale a therapeutically-effective concentration of gaseous nitric oxide (1,10) or a therapeutically-effective amount of a nitric oxide-releasing compound (106), and an inhaler device (102) containing nitric oxide gas and/or a nitric oxide-releasing compound.
Patent ES-2150404-T1 (ES)
Title: Composiciones farmaceuticas de tizoxanida y nitozoxanida.
Inventor: ROSSIGNOL JEAN-FRANCOIS
IPC: A61P37/04
Filed: 1998-05-06
Abstract: Una composición farmacéutica para administración oral caracterizada porque comprende como agente activo al menos un compuesto seleccionado del grupo integrado por: el compuesto de fórmula (I) y el compuesto de la fórmula (II).
Patent CY-1109794-T1 (CY)
Inventor: NAPOLITANO ELIO
IPC: C07D265/30
Filed: 2010-02-09
Abstract: It is disclosed a process for the preparation of 2-(4-hydroxy-3-morfolinyl)-2-cycloesenone (BTG-1675A) comprising the steps of: i) reacting N-hydroxymorpholine with cycloesanone in the presence of an oxidation agent thus obtaining an isoxazolidine of Formula IV; and ii) converting the isoxazolidine of Formula IV into 2-(4-hydroxy-3-morfolinyl)-2-cycloesenone. Advantageously, the oxidation agent of the step i) is selected from the group consisting of metal oxides, esters and amides of the azodicarboxylic acid and the step ii) of conversion is carried out by basic catalysis followed by trituration in an aromatic hydrocarbon, preferably toluene. The process disclosed allows to obtain BTG-1675A according to the invention in an amount of hundreds of grams and on an industrial scale. The invention further concerns a new process for preparing hydroxylamines, particularly N-hydroxymorpholine, which is used in the process for preparing BTG-1675A.
Patent CY-1110648-T1 (CY)
Inventor: RICE KENNETH D
IPC: C07D451/02
Filed: 2010-06-01
Abstract: A compound according to Formula I or II: wherein R1, R1b, R2, L1, and L2 and L2b are as defined in the specification, pharmaceutical compositions thereof, and methods of use thereof.
Patent CY-1110809-T1 (CY)
Title: Πυριδινες, πυριμιδινες, πυραζινες και τριαζινες υποκατεστημενες με αρυλιο και η χρηση αυτων
Inventor: HOGENKAMP DERK J
IPC: C07D403/04
Filed: 2010-09-28
Abstract: Η παρούσα εφεύρεση σχετίζεται με πυριδίνες, πυριμίδες, πυραζίνες και τριαζίνες του χημικού τύπου (I) υποκατεστημένες με αρύλια: ή κάποιο φαρμακευτικά αποδεκτό άλας, προφάρμακο ή επιδιαλυτωμένη ένωση αυτών, όπου τα Α1, Α2, Α3, R1-R4, Χ και Υ ορίζονται στην περιγραφή. Η εφεύρεση στρέφεται επίσης στη χρήση των ενώσεων του χημικού τύπου I για την αντιμετώπιση των νευρωνικών βλαβών μετά από κάποια καθολική και εστιακή ισχαιμία, για την αντιμετώπιση ή την πρόληψη νευροεκφυλιστικών παθήσεων όπως η πλάγια αμυοτροφική σκλήρυνση (ALS) και για την αντιμετώπιση, την πρόληψη ή τη βελτίωση τόσο του οξέος όσο και του χρόνιου πόνου, ως ουσίες καταπολέμησης των εμβοών, ως αντισπασμωδικά και ως ουσίες κατά της μανιοκατάθλιψης, ως τοπικά αναισθητικά, ως αντιαρρυθμικά και για την αντιμετώπιση ή την πρόληψη της διαβητικής νευροπάθειας.
Patent CY-1112787-T1 (CY)
Inventor: SPRECHER CINDY A
IPC: C07K14/715
Filed: 2012-05-25
Abstract: There is provided an antibody or antibody fragment that specifically binds to a multimeric or heterodimeric cytokine receptor, wherein the multimeric or heterodimeric cytokine receptor comprises: 
a first polypeptide consisting of amino acid residues 20-732 of SEQ ID NO:111; and 
a second polypeptide consisting of amino acid residues 28-429, amino acid residues 28-739 or amino acid residues 28-979 of SEQ ID NO:7.
Patent CY-1113441-T1 (CY)
Title: Δραστικα αναλογα κομπστατινης
Inventor: LAMBRIS JOHN D
IPC: A61K38/08
Filed: 2012-08-09
Abstract: Αποκαλύπτονται ενώσεις που περιλαμβάνουν πεπτίδια και πεπτιδομιμητικά ικανά σύνδεσης πρωτεΐνης C3 και αναστολείς ενεργοποίησης συμπληρώματος. Αυτές οι ενώσεις εμφανίζουν πολύ βελτιωμένη ανασταλτική δραστικότητα ενεργοποίησης συμπληρώματος εν συγκρίσει με σήμερα διαθέσιμες ενώσεις.
Patent CY-1114298-T1 (CY)
Title: Διαμορφωτικως περιορισμενα διφαινυλ παραγωγα για χρηση ως αναστολεις ιου ηπατιτιδας c
Inventor: BACHAND CAROL
IPC: A61P31/14
Filed: 2013-07-16
Abstract: Η παρούσα αποκάλυψη αφορά ενώσεις, συνθέσεις, και μεθόδους για τη θεραπευτική αγωγή μόλυνσης από ιό ηπατίτιδας C (ΗCV). Επίσης αποκαλύπτονται φαρμακευτικές συνθέσεις, οι οποίες περιέχουν τέτοιες ενώσεις και μέθοδοι για τη χρήση αυτών των ενώσεων στη θεραπευτική αγωγή μόλυνσης από ΗCV.
Patent CY-1114401-T1 (CY)
Title: Αντιμετωπιση τυπου 2 διαβητη με ενα συνδυασμο dpiv αναστολεα και μετφορμινης ή θειαζολιδινοδιονης
Inventor: RACHMAN JONATHAN
IPC: A61P3/10
Filed: 2013-09-09
Abstract: Η εφεύρεση αυτή σχετίζεται με μία θεραπευτική μέθοδο για γλυκαιμικό έλεγχο, συγκεκριμένα με μία μέθοδο για την αντιμετώπιση τύπου 2 διαβήτη, η οποία περιλαμβάνει τη χορήγηση ενός DPIV αναστολέα μαζί με μετφορμίνη ή μια θειαζολιδινοδιόνη.
Patent CY-1118460-T1 (CY)
Title: Συστημα και μεθοδος για τη δημιουργια του προφιλ ενος οδηγου
Inventor: JELBERT RICHARD
IPC: G07C5/08
Filed: 2017-01-17
Abstract: Μια μέθοδος που εφαρμόζεται σε υπολογιστή για τη δημιουργία του προφίλ ενός οδηγού που περιλαμβάνει: την αναγνώριση συμβάντων σε δεδομένα, τα οποία αντιπροσωπεύουν την κίνηση ενός οχήματος, για τα συμβάντα, τη συσχέτιση ενός συμβάντος με ένα δείκτη προφίλ, ο οποίος αφορά σε τουλάχιστον μία σύνδεση επί της οποίας ταξίδευε το όχημα, όταν συνέβη το αντίστοιχο συμβάν, την ταξινόμηση των συμβάντων σε ομάδες, όπου κάθε ομάδα αντιστοιχεί σε ένα διαφορετικό δείκτη προφίλ, τον προσδιορισμό ενός προφίλ οδηγού από τα συμβάντα και το χαρακτηρισμό της οδηγικής συμπεριφοράς του οδηγού βάσει του προφίλ του οδηγού.
Patent CY-1119569-T1 (CY)
Title: Μυκητοκτονες ενωσεις και μειγματα
Inventor: GREGORY VANN
IPC: C07D277/00
Filed: 2017-09-21
Abstract: Αποκαλύπτεται μυκητοκτόνος σύνθεση που περιλαμβάνει (α) τουλάχιστον μία ένωση επιλεγόμενη από τις ενώσεις του Τύπου 1, Ν-οξείδια, και άλατα αυτών, όπου οι R1, R2, A, G, W, Ζ1, Χ, J και n είναι όπως ορίζονται στην αποκάλυψη, και (β) τουλάχιστον μία επιπρόσθετη μυκητοκτόνο ένωση. Επίσης αποκαλύπτεται μέθοδος για καταπολέμηση φυτικών παθήσεων προκαλούμενων από μυκητιακά φυτοπαθογόνα περιλαμβάνουσα στάδιο εφαρμογής στο φυτό ή τμήμα αυτού, ή στο σπόρο φυτού, ποσότητας της προαναφερθείσας σύνθεσης αποτελεσματικής από μυκητοκτόνο άποψη. Επίσης αποκαλύπτεται σύνθεση που περιλαμβάνει συνιστώσα (α) της προαναφερθείσας σύνθεσης και τουλάχιστον ένα εντομοκτόνο. Επίσης αποκαλύπτονται ενώσεις του Τύπου 1Α, 1Β, και 1C, όπου οι R1, R2, A, G, W, Ζ1, Χ, J, η, Ζ3, Μ και J1 είναι όπως ορίζονται στην αποκάλυψη.
Patent CY-1122826-T1 (CY)
Title: Προ-συντηξης rsv f αντιγονα
Inventor: SWANSON KURT
IPC: C07K14/135
Filed: 2020-03-26
Abstract: Η εφεύρεση αφορά σε προ-σύντηξης RSV F πρωτεΐνη και πολυπεπτίδια που περιέχουν μία ή περισσότερες μεταλλάξεις αμινοξέος που σταθεροποιούν τη προ-σύντηξης διαμόρφωση ή αποσταθεροποιούν τη μετά τη σύντηξη διαμόρφωση. Η εφεύρεση επίσης αφορά σε μεθόδους για διέγερση ανοσοαπόκρισης προς προ-σύντηξης RSV F.
Patent GR-890300031-T1 (GR)
Title: Power shaped multipad hydrodynamic journal bearing
Inventor: GIRIDHARI AGRAWAL LAL
IPC: F16C17/12
Filed: 1989-04-12
Abstract: A fixed shape hydrodynamic journal bearing (l0) is provided having a plurality of pads(18),each pad having a peak(22) ,a trough(20) ,and a curve(24) connecting the peak and the trough, the curve being defined by the equation: h = r + s (1- theta 1/ theta 2)< alpha >.